Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences

On November 23, 2022 Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, reported that the management team will participate in and attend one-on-one meetings at two upcoming investor conferences (Press release, Gracell Biotechnologies, NOV 23, 2022, View Source [SID1234624407]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Piper Sandler 34th Annual Healthcare Conference
Presentation: November 30th at 4:00 pm ET
One-on-one meetings: Wednesday, November 30, 2022
Location: New York, NY

JMP Securities Hematology & Oncology Summit (virtual)
Presentation: December 7th at 10:00 am ET
One-on-one meetings: December 6 – 7, 2022

Webcast of the fireside chat will be available on the News and Events section of Gracell’s investor website. A replay of the webcast will be available for 30 days following the event.